Dow Jones

40 211,72

0,00%

DAX

Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.

S'inscrire

Accueil
Investir
Actions
Italie
BIT
Abitare In Spa (ABT)
Abitare In Spa (ABT) Actualités

ABT

Abitare In (ABT)

Abitare In Spa

De:

Actualités Réglementées

Mots clefs:

Trier par:

Actualités Non-réglementées

Showing the most relevant articles for your search:BIT:ABT

<< Précédent 13 14 15 16 17 18 19 20 21 22 23 24 25 Suivant >>

Date	Heure	Source	Titre	Symbole	Société
22/01/2007	16h00	PR Newswire (US)	Abbott Nutrition to Host 'The ZonePerfect(R) Bar' Music Series at 2007 Sundance Film Festival	NYSE:ABT
11/01/2007	14h50	PR Newswire (US)	Private-Label Version of Abbott's XIENCE(TM)V Drug-Eluting Coronary Stent System Launches in Europe	NYSE:ABT
14/12/2006	14h45	PR Newswire (US)	Abbott Fund Supports Pioneering Malaria Education Program	NYSE:ABT
28/11/2006	16h15	PR Newswire (US)	Children Affected by HIV/AIDS Around the World Bring Their Photographs and Stories to Chicago for the First Time	NYSE:ABT
23/10/2006	15h00	PR Newswire (US)	New Phase III Data Shows Abbott's HUMIRA(R) (Adalimumab) Induced Clinical Remission In Patients With Crohn's Disease Who Lost Re	NYSE:ABT
22/08/2006	17h10	PR Newswire (US)	Rising Medical Costs Biggest Challenge for Diabetes Patients in Managing the Condition	NYSE:ABT
02/08/2006	21h46	PR Newswire (US)	S&P Equity Research Has Positive View on New Medicare Medical Device Reimbursement Rules	NYSE:ABT
19/07/2006	21h00	PR Newswire (US)	Abbott Announces FDA Clearance of Cell-Dyn Ruby(TM) Hematology Instrument	NYSE:ABT
09/05/2006	15h00	PR Newswire (US)	Abbott to Present at Banc of America Securities Health Care Conference	NYSE:ABT
28/04/2006	14h30	PR Newswire (US)	Abbott's HUMIRA(R) (Adalimumab) Receives Positive Opinion From European Medicines Agency for the Treatment of Ankylosing Spondy	NYSE:ABT
11/11/2005	03h06	PR Newswire (US)	U.S. District Court Grants Abbott's Request for a Preliminary Injunction Against Biaxin(R) XL Generics	NYSE:ABT
31/10/2005	14h04	PR Newswire (US)	Abbott Receives FDA Approval for New Kaletra(R) (Lopinavir/Ritonavir) Tablet Formulation for HIV Patients	NYSE:ABT
24/08/2005	14h00	PR Newswire (US)	Wal-Mart Hosts Child Safety Education Event Nationwide	NYSE:ABT
09/07/2005	07h21	PR Newswire (US)	Abbott Statement on Agreement With Brazilian Government for Kaletra(R) (Lopinavir/Ritonavir)	NYSE:ABT
14/06/2005	23h00	PR Newswire (US)	Getting Arms Around Childhood Obesity Focus of Colorado Summit	NYSE:ABT
10/06/2005	18h54	PR Newswire (US)	Abbott Declares 326th Consecutive Quarterly Dividend	NYSE:ABT
12/05/2005	17h55	PR Newswire (US)	Recent College Graduates Find Success at Abbott	NYSE:ABT
27/04/2005	17h00	PR Newswire (US)	Creative Way to Calm a Fussy Baby May Win a 'Fuss-Free' Trip For Mom	NYSE:ABT
11/04/2005	20h00	PR Newswire (US)	Abbott Named No. 5 to DiversityInc's Top 50 Companies for Diversity list	NYSE:ABT
05/04/2005	14h00	PR Newswire (US)	Abbott Joins National Program to Help Millions of Uninsured Americans Get the Prescription Medicines They Need	NYSE:ABT
11/02/2005	21h12	PR Newswire (US)	FDA Agrees to File Abbott's New Drug Application for Xinlay(TM) (Atrasentan) to Treat Metastatic Hormone-Refractory Prostate Can	NYSE:ABT
25/01/2005	16h00	PR Newswire (US)	FDA Approves First Gene-Based Test, UroVysion(TM), for Diagnosis of Patients Suspected of Having Bladder Cancer	NYSE:ABT
15/12/2004	17h55	PR Newswire (US)	TAP Submits New Drug Application for Febuxostat for the Management of Hyperuricemia in Chronic Gout	NYSE:ABT
01/11/2004	17h24	PR Newswire (US)	Longest Study of Kaletra(R) (Lopinavir/Ritonavir) Based Regimen Demonstrated Favorable Resistance Profile for Patients Through S	NYSE:ABT
01/11/2004	16h00	PR Newswire (US)	/C O R R E C T I O N -- Abbott Laboratories/	NYSE:ABT
28/10/2004	20h00	PR Newswire (US)	Superstar Patti LaBelle Encourages Americans to Manage Diabetes 365 Days a Year	NYSE:ABT
15/09/2004	17h00	PR Newswire (US)	Abbott's On-Site Child Care Center Recognized Amongst the Country's Best	NYSE:ABT
27/07/2004	17h00	PR Newswire (US)	Abbott Laboratories Introduces First Fully Automated Test for Hepatitis A Virus	NYSE:ABT
14/07/2004	23h14	PR Newswire (US)	U.S. District Court Dismisses Claims Against Abbott Laboratories' Anti-Obesity Medication Meridia(R) (Sibutramine HCL Monohydrat	NYSE:ABT
14/07/2004	15h30	PR Newswire (US)	Kaletra(R) (lopinavir/ritonavir) Based Regimens Demonstrate Favorable Resistance in Clinical Trials	NYSE:ABT